Literature DB >> 21234797

Modulation of LPA receptor expression in the human brain following neurotrauma.

Tony Frugier1, Duncan Crombie, Alison Conquest, Frisca Tjhong, Caroline Taylor, Tejal Kulkarni, Catriona McLean, Alice Pébay.   

Abstract

Lysophosphatidic acid (LPA) is involved in physiological and pathological states, including in neural development and inflammation. We assessed the expression pattern of the LPA receptors 1-3 and of LPA-producing enzyme autotaxin in post-mortem human brain tissue, both in normal individuals and in individuals who died following traumatic brain injury. We found that LPA receptors and autotaxin are weakly expressed in the normal control adult brain. Quantitative PCR for the LPA receptors and autotaxin mRNA showed an increase of LPAR(2) and a decrease of autotaxin mRNA expression in the cortex following brain injury. Immunohistochemical analysis showed that LPAR(1) colocalized with astrocytes and that LPAR(2) is present on the ependymal cells lining the lateral ventricle in the brain samples from individuals who died following severe head injury. This work shows for the first time that key components of the LPA pathway are modulated following TBI in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234797     DOI: 10.1007/s10571-011-9650-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  41 in total

1.  The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern.

Authors:  J J Contos; J Chun
Journal:  Gene       Date:  2001-04-18       Impact factor: 3.688

2.  Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma.

Authors:  N E Savaskan; L Rocha; M R Kotter; A Baer; G Lubec; L A van Meeteren; Y Kishi; J Aoki; W H Moolenaar; R Nitsch; A U Bräuer
Journal:  Cell Mol Life Sci       Date:  2007-01       Impact factor: 9.261

3.  LPA-mediated demyelination in ex vivo culture of dorsal root.

Authors:  Ryousuke Fujita; Norikazu Kiguchi; Hiroshi Ueda
Journal:  Neurochem Int       Date:  2006-10-23       Impact factor: 3.921

4.  Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain.

Authors:  M Narita; J Goji; H Nakamura; K Sano
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

Review 5.  Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.

Authors:  Jameel Dennis; Luciana Nogaroli; Babette Fuss
Journal:  J Neurosci Res       Date:  2005-12-15       Impact factor: 4.164

6.  LPA receptor expression in the central nervous system in health and following injury.

Authors:  Yona Goldshmit; Kathryn Munro; Soo Yuen Leong; Alice Pébay; Ann M Turnley
Journal:  Cell Tissue Res       Date:  2010-05-22       Impact factor: 5.249

Review 7.  Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms.

Authors:  Hiroshi Ueda
Journal:  Pharmacol Ther       Date:  2005-07-15       Impact factor: 12.310

8.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.

Authors:  Silvia Jansen; Cristiana Stefan; John W M Creemers; Etienne Waelkens; Aleyde Van Eynde; Willy Stalmans; Mathieu Bollen
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

9.  LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.

Authors:  Chang-Wook Lee; Richard Rivera; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-12-13       Impact factor: 5.157

Review 10.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04
View more
  22 in total

1.  Differential Gene Expression Associated with Meningeal Injury in Acute Mild Traumatic Brain Injury.

Authors:  Whitney S Livingston; Jessica M Gill; Martin R Cota; Anlys Olivera; Jessica L O'Keefe; Christiana Martin; Lawrence L Latour
Journal:  J Neurotrauma       Date:  2016-08-30       Impact factor: 5.269

2.  Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

Authors:  Yona Goldshmit; Rosalia Matteo; Tamar Sztal; Felix Ellett; Frisca Frisca; Kelli Moreno; Duncan Crombie; Graham J Lieschke; Peter D Currie; Roger A Sabbadini; Alice Pébay
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

Review 3.  Lysophosphatidic Acid signaling in the nervous system.

Authors:  Yun C Yung; Nicole C Stoddard; Hope Mirendil; Jerold Chun
Journal:  Neuron       Date:  2015-02-18       Impact factor: 17.173

4.  Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular Pathology.

Authors:  Whitney S McDonald; Elizabeth E Jones; Jonathan M Wojciak; Richard R Drake; Roger A Sabbadini; Neil G Harris
Journal:  Am J Pathol       Date:  2018-07-16       Impact factor: 4.307

Review 5.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 6.  Lysophosphatidic Acid Signalling in Nervous System Development and Function.

Authors:  Eric Birgbauer
Journal:  Neuromolecular Med       Date:  2020-11-05       Impact factor: 3.843

7.  Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.

Authors:  Edwin B Yan; Tony Frugier; Chai K Lim; Benjamin Heng; Gayathri Sundaram; May Tan; Jeffrey V Rosenfeld; David W Walker; Gilles J Guillemin; Maria Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2015-05-30       Impact factor: 8.322

Review 8.  The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.

Authors:  Sadaharu Tabuchi
Journal:  Lipids Health Dis       Date:  2015-06-18       Impact factor: 3.876

Review 9.  Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions.

Authors:  Sun-Hye Choi; Seok-Won Jung; Byung-Hwan Lee; Hyeon-Joong Kim; Sung-Hee Hwang; Ho-Kyoung Kim; Seung-Yeol Nah
Journal:  Front Pharmacol       Date:  2015-10-27       Impact factor: 5.810

10.  Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

Authors:  Peter J Crack; Moses Zhang; Maria Cristina Morganti-Kossmann; Andrew J Morris; Jonathan M Wojciak; Jonathan K Fleming; Ila Karve; David Wright; Maithili Sashindranath; Yona Goldshmit; Alison Conquest; Maria Daglas; Leigh A Johnston; Robert L Medcalf; Roger A Sabbadini; Alice Pébay
Journal:  J Neuroinflammation       Date:  2014-02-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.